This ETF offers investors the chance to buy into the Brazilian equity market, making FBZ one of a handful of products offering exposure to one of the world's largest and most strategically important emerging markets. FBZ could potentially be included in a long-term portfolio, though the inclusion of Brazilian equities in most broad based emerging market or Latin America ETFs may result in duplication of exposure. This ETF might be most useful for investors with a bullish outlook on Brazil's stock market looking to establish a tactical tilt towards the South American economy. FBZ is somewhat unique as a result of the methodology used to construct and maintain the underlying index; this ETF is part of the AlphaDEX suite from First Trust that seek to replicate "enhanced" indexes. Instead of simply owning the market, the index to which FBZ is linked employs a quant-based screen designed to identify stocks with the greatest potential for capital appreciation. In return for this enhanced strategy and chance to generate alpha, investors will pay a bit more; FBZ maintains an expense ratio that is a bit higher than other Brazil ETFs such as EWZ. If you believe the AlphaDEX methodology has the ability to generate excess returns over the long run, FBZ might be the preferred means of gaining exposure to Brazilian stock markets. Those who prefer to own the market and avoid more expensive quant-based techniques may prefer EWZ for large cap exposure or BRAZ for mid cap exposure (EWZS and BRF are available to those looking to bet on small caps). It should also be noted that the AlphaDEX methodology has a unique impact on the portfolio of FBZ compared to cap-weighted products such as EWZ; the AlphaDEX product avoids big concentrations in any one name, while the cap-weighted fund affords hefty weights to a couple of mega cap companies. As such, FBZ may offer more balanced exposure to the Brazilian economy and minimize the impact of any company-specific developments on the ETF's performance. Investors seeking broader exposure to Latin American stocks through the AlphaDEX methodology may want to take a look at FLN.
The adjacent table gives investors an individual Realtime Rating for FBZ on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Latin America Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.View the Category Report
The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb Category.
This ETF is not currently available for commission free trading on any platforms.
There are 8 other ETFs in the Latin America Equities ETFdb Category that are also eligible for commission free trading:
This section shows how this ETF has performed relative to its peer group ETFdb Category.
The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.
The following chart also includes the option to compare the performance of FBZ relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.
This section shows how the volatility of this ETF compares to the peer group ETFdb Category.
2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.